IL91070A0 - Cytotoxic agent against specific virus infection - Google Patents

Cytotoxic agent against specific virus infection

Info

Publication number
IL91070A0
IL91070A0 IL8991070A IL9107089A IL91070A0 IL 91070 A0 IL91070 A0 IL 91070A0 IL 8991070 A IL8991070 A IL 8991070A IL 9107089 A IL9107089 A IL 9107089A IL 91070 A0 IL91070 A0 IL 91070A0
Authority
IL
Israel
Prior art keywords
virus infection
cytotoxic agent
agent against
against specific
specific virus
Prior art date
Application number
IL8991070A
Other versions
IL91070A (en
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27397211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL91070(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/223,270 external-priority patent/US5206353A/en
Application filed by Us Commerce filed Critical Us Commerce
Publication of IL91070A0 publication Critical patent/IL91070A0/en
Publication of IL91070A publication Critical patent/IL91070A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70514CD4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/32Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/55Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL9107089A 1988-07-23 1989-07-21 Cytotoxic agent against specific virus infection IL91070A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/223,270 US5206353A (en) 1988-07-23 1988-07-23 CD-4/cytotoxic gene fusions
US28373988A 1988-12-13 1988-12-13
US34430489A 1989-04-27 1989-04-27

Publications (2)

Publication Number Publication Date
IL91070A0 true IL91070A0 (en) 1990-02-09
IL91070A IL91070A (en) 1995-03-30

Family

ID=27397211

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9107089A IL91070A (en) 1988-07-23 1989-07-21 Cytotoxic agent against specific virus infection

Country Status (3)

Country Link
EP (1) EP0428603A4 (en)
IL (1) IL91070A (en)
WO (1) WO1990001035A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498538A (en) * 1990-02-15 1996-03-12 The University Of North Carolina At Chapel Hill Totally synthetic affinity reagents
EP0542761B1 (en) * 1990-08-06 1994-09-14 The Upjohn Company Eliminating internal initiation of soluble cd4 gene
US6099842A (en) * 1990-12-03 2000-08-08 The United States Of America As Represented By The Department Of Health And Human Services Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin
CA2080226C (en) 1991-02-08 2004-05-04 Gary A. Beaudry Cd4-gamma2 and cd4-igg2 chimeras
US7070991B2 (en) 1991-02-08 2006-07-04 Progenics Pharmaceuticals, Inc. Cells expressing a CD4-IgG2 chimeric heterotetramer
US5234905A (en) * 1991-02-22 1993-08-10 University Of Colorado Foundation, Inc. Soluble CD4 molecules modified to prolong circulating half-life
GB9217124D0 (en) * 1992-08-13 1992-09-23 Antisoma Ltd Medical treatment
AU5098393A (en) * 1992-08-14 1994-03-15 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Recombinant toxin with increased half-life

Also Published As

Publication number Publication date
IL91070A (en) 1995-03-30
EP0428603A1 (en) 1991-05-29
EP0428603A4 (en) 1991-11-13
WO1990001035A1 (en) 1990-02-08

Similar Documents

Publication Publication Date Title
GB9027250D0 (en) Viral agent
GB8820945D0 (en) Medical articles
ZA902096B (en) Intraoral medication releasing system
AU9128891A (en) Single use syringe
PH25605A (en) 16-dehydro-vitamin d3-derivatives, medicament contatining said compounds
ZA901879B (en) Medicament
ZA903716B (en) Infection barrier
AU4918790A (en) Medicament
IL91070A0 (en) Cytotoxic agent against specific virus infection
AU649061B2 (en) Single use syringe
EP0406416A4 (en) Anti-hiv agent
HU905823D0 (en) Medical preparations
GB9016375D0 (en) Syringe
AU107847S (en) Syringe
ZA90840B (en) Medicament
GB8928418D0 (en) Novel-anti-viral and cytotoxic agent
GB9022669D0 (en) Medicament
GB8928562D0 (en) Viral agent
CA66409S (en) Syringe
CA66344S (en) Syringe
CA65932S (en) Syringe
RU1769716C (en) Syringe
CS82190A2 (en) Safe syringe
ZA895825B (en) Anthelmintic compounds,their preparation and use
PL276446A2 (en) Antiprespiration agent

Legal Events

Date Code Title Description
RH Patent void